DeCaprio J A, Ludlow J W, Lynch D, Furukawa Y, Griffin J, Piwnica-Worms H, Huang C M, Livingston D M
Dana-Farber Cancer Institute, Boston, Massachusetts 02115.
Cell. 1989 Sep 22;58(6):1085-95. doi: 10.1016/0092-8674(89)90507-2.
The retinoblastoma susceptibility gene product, Rb, is suspected to suppress cell growth. Rb is a 110-114 kd nuclear phosphoprotein. We have previously demonstrated that SV40 T antigen binds only to unphosphorylated Rb, and not pp112-114Rb, the family of phosphorylated Rb. Here we demonstrate the cell cycle-dependent phosphorylation of Rb. In G0/G1 cells, virtually all the Rb is unphosphorylated. In contrast, during S and G2, it is largely, if not exclusively, phosphorylated. Rb phosphorylation occurs at the G1/S boundary in several cell types tested. A 14 residue peptide, corresponding to the SV40 T domain required for transformation, is able to compete effectively with SV40 T for binding to p110Rb. We propose a model to explain how Rb may suppress cell growth by acting as a cell cycle regulatory element.
视网膜母细胞瘤易感基因产物Rb被怀疑具有抑制细胞生长的作用。Rb是一种110 - 114kd的核磷蛋白。我们先前已经证明,SV40 T抗原仅与未磷酸化的Rb结合,而不与磷酸化Rb家族的pp112 - 114Rb结合。在此我们证明了Rb的细胞周期依赖性磷酸化。在G0/G1期细胞中,几乎所有的Rb都是未磷酸化的。相反,在S期和G2期,它即使不是完全磷酸化,也是大部分磷酸化的。在几种测试的细胞类型中,Rb磷酸化发生在G1/S边界。一个与转化所需的SV40 T结构域相对应的14个残基的肽,能够与SV40 T有效竞争,以结合p110Rb。我们提出一个模型来解释Rb如何通过作为细胞周期调节元件来抑制细胞生长。